Company Filing History:
Years Active: 2014
Title: Innovations in Gastric Cancer Detection by Katie Wing Kei Lam
Introduction
Katie Wing Kei Lam is a prominent inventor based in Hong Kong, CN. He has made significant contributions to the field of medical diagnostics, particularly in the early detection of gastric cancer. His innovative work has the potential to improve patient outcomes through timely diagnosis.
Latest Patents
Katie Wing Kei Lam holds a patent titled "Biomarkers of gastric cancer and use thereof." This patent encompasses a set of biomarkers that are indicative of early gastric cancer. The method involves diagnosing gastric cancer at an early stage by detecting these biomarkers in a blood sample. The detection of over-expression of specific protein biomarkers, such as albumin, T-kininogen I, α-2-HS glycoprotein, α-1-antitrypsin, afamin, and γ-actin, along with the under-expression of others like stress 70 protein, apolipoprotein A-I, apolipoprotein A-IV, transthyretin, and murinoglobulin, is indicative of the presence of gastric cancer. He has 1 patent in this area.
Career Highlights
Katie Wing Kei Lam is affiliated with The Hong Kong Polytechnic University, where he continues to advance his research in medical diagnostics. His work is recognized for its potential impact on early cancer detection and treatment strategies.
Collaborations
Katie collaborates with Samuel Chun-Lap Lo, contributing to the development of innovative diagnostic methods in the field of oncology.
Conclusion
Katie Wing Kei Lam's contributions to the detection of gastric cancer through innovative biomarkers highlight the importance of early diagnosis in improving patient care. His work exemplifies the intersection of research and practical application in the medical field.